Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

about

Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

Item

http://www.wikidata.org/entity/Q36774320

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

@ast

Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

@en

type

Item

label

Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

@ast

Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

@en

prefLabel

Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

@ast

Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

@en

P1476

Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

@en

P2093

Fangxi Zhang

http://www.w3.org/2001/XMLSchema#string

Hongbo Wang

http://www.w3.org/2001/XMLSchema#string

Jing Shao

http://www.w3.org/2001/XMLSchema#string

Jingwei Tian

http://www.w3.org/2001/XMLSchema#string

Liang Ye

http://www.w3.org/2001/XMLSchema#string

Qiaofeng Liu

http://www.w3.org/2001/XMLSchema#string

Xiangjing Meng

http://www.w3.org/2001/XMLSchema#string

Yan Zhong

http://www.w3.org/2001/XMLSchema#string

P2860

Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties

The mesolimbic dopamine reward circuit in depression

A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation.

Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.

Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.

Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis

The HPA axis in major depression: classical theories and new developments.

P2888

srep24233

P304

24233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP24233

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

300001113

http://www.w3.org/2001/XMLSchema#string

P6179

1017068942

http://www.w3.org/2001/XMLSchema#string

P698

27052887

http://www.w3.org/2001/XMLSchema#string

P932

4823741

http://www.w3.org/2001/XMLSchema#string